Rad Technology Medical Systems LLC is categorized under Commercial Medical Research in Miami, FL and active since 2006.
Rad Technology Medical Systems LLC was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact John Lefkus at the company’s single location by writing to 20801 Biscayne Boulevard, Miami, Florida FL 33180 or by phoning (954) 257-8686. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Rad Technology Medical Systems LLC |
Contact Person: | John Lefkus |
Address: | 20801 Biscayne Boulevard, Miami, Florida 33180 |
Phone Number: | (954) 257-8686 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Medical Research |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Rad Technology Medical Systems LLC was started in 2006 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact John Lefkus for inquiries that concern Rad Technology Medical Systems LLC by calling the company number (954) 257-8686, as your correspondence is most welcome. Additionally, the physical location of the single location of Rad Technology Medical Systems LLC can be found at the coordinates 25.96801,-80.144753 as well as the street address 20801 Biscayne Boulevard in Miami, Florida 33180.
For its online presence, you may visit Rad Technology Medical Systems LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.